Ennature Bio Pharma Limited lists on NSE and BSE, reporting Rs 246 crore in FY26 revenue, driven by growth in branded nutraceuticals.
Honasa Consumer Limited (HONASA) acquires 58% in Fluence Pharma, entering nutraceuticals with patented Cyclical Nutrition Therapy.